The effect of chronic DOAC treatment on clinical outcomes of hospitalized patients with COVID‐19
International Journal of Clinical Practice2021Vol. 75(9), pp. e14467–e14467
Citations Over TimeTop 10% of 2021 papers
Burhan Aslan, Abdurrahman Akyüz, Ferhat Işık, Murat Çap, Ümit İnci, İlyas Kaya, Mehmet Zülküf Karahan, Adem Aktan, Önder Bilge, Mehmet Özbek, Bernas Altıntaş, Bedrettin Boyraz
Abstract
Our study showed that the use of DOAC prior to hospitalization had no protective effect on in-hospital mortality and intensive care need in hospitalized COVID-19 patients.
Related Papers
- → The reproductive number of COVID-19 is higher compared to SARS coronavirus(2020)3,461 cited
- → Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV)(2020)32 cited
- → And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan(2020)27 cited
- → Wearing masks and the fight against the novel coronavirus (COVID-19)(2020)7 cited